KP Tissue

KPT.TO

Household & Personal Products · Consumer Defensive

Price

C$12.75

+0.04 (+0.31%)

Market Cap

C$127.9M

Exchange

Toronto Stock Exchange

Winston Score

–

No score yet — Winston is napping.

We couldn’t gather enough financial data to score this stock reliably.

Track this stock — start free trial

Share count rising — dilution

+1.7% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 9.8M (2021) → 10.0M (2025)

Winston Score History

The full picture

KP Tissue Inc. is a Canadian company that makes tissue paper products like toilet paper, paper towels, facial tissues, and napkins. It sells these everyday household products to grocery stores, retailers, and other businesses across Canada. The company owns a stake in Kruger Products, which is one of the largest tissue manufacturers in Canada and makes well-known brands like Cashmere, Purex, SpongeTowels, and White Swan.

KP Tissue earns money through Kruger Products by selling both branded and private-label tissue products to retailers. It operates primarily in Canada but Kruger Products also has some manufacturing and sales presence in the United States. The tissue market is competitive, with large global players like Procter & Gamble and Kimberly-Clark putting pressure on pricing and shelf space. The main risk the company faces is rising input costs — things like pulp, energy, and transportation — which can squeeze profit margins when prices go up faster than the company can pass costs on to customers.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

N/A

—

Data not available

Profit after running costs

Operating Margin

N/A

—

Data not available

Return on the money invested

ROCE

0.0%

Weak — 0.0% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

N/A

—

Data not available

Profit growth

EPS YoY

+196.7%

Earnings growing fast (+196.7% YoY)

Earnings growing 25%+ a year. The compounder zone.

How steady the profit is

EPS Consistency

5/8 quarters

Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

Weak — only 0% of profit becomes cash

Spare cash per sale

FCF Margin

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

N/A

Data not available

Covers its interest

Interest Cover

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

14.3x

Attractive valuation — P/E 14.3

P/E in the normal range. Price is roughly $15 for every $1 of yearly profit.

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend

Dividend Yield

6.59%

Healthy income — 6.59% yield

Yield above 6% — often a flag the market is pricing in a cut.

Dividend record

Dividend Growth

+8.3%

Dividend growing modestly (8.3% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial